title: The impact of myeloid growth factors on engraftment following autologous bone marrow transplantation for malignant lymphoma.
authors.affiliation: Division of Tumor Immunology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
authors.forename: S N
authors.initials: SN
authors.lastname: Rabinowe
authors.forename: J
authors.initials: J
authors.lastname: Nemunaitis
authors.forename: J
authors.initials: J
authors.lastname: Armitage
authors.forename: L M
authors.initials: LM
authors.lastname: Nadler
mesh_terms: D016026:Bone Marrow Transplantation; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor